Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Authors: Nicolas Richard, Philippe Seksik, Romain Altwegg, Maria Nachury, David Laharie, Stéphane Nancey, Benoît Coffin, Anne‐Laure Pelletier, Mathieu Uzzan, Aurélien Amiot, Morgane Amil, Lucine Vuitton, Mathurin Fumery, Anne Bozon
Format: Artículo Open Access
Published: Wiley 2026
Subjects:
Alimentary Pharmacology & Therapeutics
Online Access:https://onlinelibrary.wiley.com/doi/10.1111/apt.70682
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View

Internet

https://onlinelibrary.wiley.com/doi/10.1111/apt.70682

Similar Items

  • Editorial: Real‐World Evidence of Upadacitinib—An Effective Induction Therapy for Crohn's Disease? Authors' Reply
    by: Nicolas Richard, et al.
    Published: (2025)
  • Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study
    by: Mathilde Osty, et al.
    Published: (2025)
  • Editorial: Upadacitinib in Perianal Crohn's Disease
    by: Manjeet Kumar Goyal, et al.
    Published: (2026)
  • Letter: Toward Intra‐Class Switching With JAK Inhibitors?
    by: Mathieu Uzzan, et al.
    Published: (2025)
  • Editorial: JAK to JAK—Navigating Intra‐Class JAK Inhibitor Switching in Inflammatory Bowel Disease. Authors' Reply
    by: Mathieu Uzzan, et al.
    Published: (2025)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs